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Introduction
Urogenital carcinoma (UGC) is the most commonly observed 
neoplasm in California sea lions (Zalophus californianus)1. This 
cancer was first reported in sea lions on the west coast of North 
America in 19792, and over a fifteen-year period, from 1998 to 
2012, the disease was found in 26 per cent of adult animals exam-
ined post-mortem at The Marine Mammal Center, California1. 
UGC affects both male and female animals, and is most frequently 
found in sexually mature adults3,4. The disease typically presents 
with extensive multi-organ metastases; however, primary lesions 
involving the genital epithelium can usually be identified5.
Three aetiological factors have been proposed for the devel-
opment of UGC: infection, host genetics, and environmental 
factors. Otarine herpesvirus type 1 (OtHV-1), a gammaherpesvi-
rus related to Kaposi’s sarcoma-linked human herpesvirus-85,6 has 
been associated with UGC5–7; however, this virus has not been 
confirmed as a causative agent. An association between UGC 
and genital bacterial infection has also been proposed8. Genetic 
studies have indicated that individuals with high parental 
relatedness9, homozygosity at the HSPE2 locus10, or one or more 
copies of the Zaca-DRB.A MHC class II locus11 have increased 
risk of UGC. Environmental contaminants, such as organo-
chlorines, have also been proposed as causative agents in UGC 
carcinogenesis12.
Cancer occurs when a somatic cell acquires mutations that drive 
it towards a program of uncontrolled clonal expansion. Although 
cancer cells can migrate and invade distant tissues, most cancers 
remain within the body of the host that spawned them. Rarely, 
however, cancers can become transmissible such that cancer cells 
themselves become infectious agents that are transferred between 
individuals as allogeneic grafts. Only eight examples of natu-
rally occurring contagious cancers are known: canine transmis-
sible venereal tumour (CTVT) found in domestic dogs13,14, two 
distinct lineages of Tasmanian devil facial tumour disease15,16, and 
five lineages of disseminated neoplasia affecting various species 
of marine bivalves17,18. Tumours derived from clonally transmis-
sible cancers carry the genetic material of the original animal 
that first gave rise to the cancer; thus, transmissible cancers are 
characterised by shared genotypes that are distinct from those of 
their matched hosts.
Several features of UGC are compatible with the possibility that 
this cancer is clonally transmissible: epidemiological observa-
tions of UGC are consistent with an infectious aetiology for the 
disease2; and, in particular, its genital localisation could provide 
a coital route of transmission19, as is observed with CTVT, the 
transmissible cancer in dogs.
We genotyped UGC tumours and their matched hosts to 
determine if UGC is clonally transmissible. Our results do not 
show evidence for UGC being a transmissible cancer, but rather 




This study was approved by The Marine Mammal Center Institu-
tional Animal Care and Use Committee (Sausalito, CA) and the 
National Marine Fisheries Service MMPA (permit number 18786).
Samples
Tissues from seven wild stranded adult California sea lions 
were collected at The Marine Mammal Center, Sausalito, CA. 
Complete gross and histopathological examinations were 
performed on each animal to confirm UGC diagnosis. Tumour 
(metastasis) and host tissue (liver or muscle) biopsies were col-
lected into RNAlater during post-mortem examination and were 
stored at −70°C until processing.
DNA extraction
Representative tissue sampled from tumour and host biopsies 
was used for DNA extraction using the Qiagen DNeasy Blood and 
Tissue Kit (Qiagen, Hilden, Germany) according to manufacturer’s 
instructions. DNA was quantified using a Qubit 2.0 fluorometer 
(Invitrogen, Carlsbad, CA, USA).
PCR
We amplified a 1289 bp fragment of the mitochondrial DNA 
(mtDNA) control region using primers described by Wolf et al20. 
PCR was performed using an Eppendorf Mastercycler Nexus GSX1 
(Eppendorf, Hamburg, Germany) with conditions as follows: 40 ng 
of genomic DNA was amplified in a total volume of 20 μl contain-
ing 0.5 μM of each primer, 0.2 mM of each dNTP and 0.02 units 
of Taq DNA polymerase (Qiagen, Hilden, Germany) per reaction. 
Cycling conditions were 95°C for 3 min, 30 cycles of 95°C for 
15 s, 60°C for 30 s, 72°C for 45 s and a final extension step at 
72°C for 5 min. PCR products were purified using a QIAquick PCR 
purification kit (Qiagen, Hilden, Germany). Purified PCR prod-
ucts were capillary sequenced at Source BioScience LifeSciences 
Genomic Services (Source BioScience LifeSciences, Nottingham, 
United Kingdom).
Alignment and variant calling
Sequences were aligned to the California sea lion mtDNA refer-
ence genome (accession number NC_008416)21 using Sequencher 
DNA Sequence Analysis Software v5.4.6 (Gene Codes, Ann Arbor, 
MI, USA). Alignment errors were inspected manually and cor-
rected. Variant positions were identified by viewing alignments, as 
well as by manual assessment of sequence chromatograms using 
FinchTV v1.4.0 (Geospiza Inc., Seattle, WA, USA). Variants were 
only assessed within a 397 bp region of the product, comprising 
region 15490–15886 in NC_008416.
Results
We assessed 397 base pairs of the mtDNA control region in 
seven UGC tumours and their matched hosts. The analysis identi-
fied nine polymorphic sites characterising four unique genotypes 
within the sampled sea lion population (Table 1). In all cases, the 
alleles present in tumours were identical to those found in matched 
host tissue (Table 1). Chromatograms were closely examined at 
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polymorphic sites, but no evidence for amplification of additional 
alleles in tumour tissues was found22.
Discussion
Our study does not support the hypothesis that UGC is clonally 
transmitted, but rather further confirms that UGC arises from host 
cells. Importantly, however, we cannot exclude the possibility that 
some UGCs are clonally transmitted. Given the genital localisation 
of this cancer, and likely accessibility of UGC cancer cells to other 
individuals during coitus, UGC tumours may pose a particular risk 
for the emergence of a transmissible cancer clone.
In this analysis we only examined genetic variation at one mtDNA 
locus. It is worth noting that at least one transmissible can-
cer – CTVT in dogs - has been observed to periodically capture 
mtDNA from its hosts23; thus, mtDNA may not be considered the 
most reliable marker for testing clonality in transmissible cancers. 
However, mtDNA horizontal transfer events were detected only 
five times in a cohort of 449 CTVT tumours24; thus even if mtDNA 
capture had occurred, it would not be expected that tumours would 
genetically match their hosts as frequently as we have observed in 
UGC.
Given that transmissible cancers are clonal lineages, tumour 
cell morphology and tissue architecture is generally very similar 
between tumours25,26. However, previous research has shown that 
UGCs appear to develop through histologically distinct stages5, 
which further supports the idea of step-wise oncogenic transfor-
mation of host tissue rather than direct transmission of a cancer 
lineage.
Future research exploring the role of viral agents, host genetics 
and environmental factors, as well as somatic genetics, will be 
important for understanding the carcinogenic processes that 
cause UGC. It is interesting to note that an OtHV-1-associated 
UGC has recently been reported in a South American fur seal 
(Arctocephalus australis)27, indicating that other pinnipeds are 
susceptible to UGC, and further implicating OtHV-1 as a causa-
tive agent. Furthermore, a recent analysis of cytological smears 
collected from California sea lions in the Gulf of California 
revealed that transformation of the genital epithelium may be 
relatively common in this species28.
Wildlife models of cancer can provide novel insights into general 
mechanisms of cancer development29. Furthermore, an understand-
ing of the aetiological factors underlying commonly observed 
cancers in wildlife is important for conservation and biomonitor-
ing. In this study, we have found no evidence that UGC, one of 
the few “cancer epidemics” in wildlife1,29, is clonally transmitted. 
Ruling out this mode of carcinogenesis is an important step in our 
understanding of UGC, and paves the way towards further research 
investigating the processes underlying this aggressive disease in sea 
lions.
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accession numbers: MF000998 - MF001011.
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